% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Gambichler:299784,
author = {T. Gambichler and S. Girke and N. Abu Rached and L. Susok
and J. Becker$^*$ and H.-J. Schulze and T. Hirsch and M.
Kückelhaus and S. Wellenbrock},
title = {{L}ow {I}ntratumoral {CD}200 {P}rotein {E}xpression in
{P}rimary {M}erkel {C}ell {C}arcinoma {I}s a {S}trong
{P}redictor for {D}isease {R}elapse.},
journal = {Cancers},
volume = {17},
number = {5},
issn = {2072-6694},
address = {Basel},
publisher = {MDPI},
reportid = {DKFZ-2025-00539},
pages = {822},
year = {2025},
abstract = {Merkel cell carcinoma (MCC) is a rare and frequently fatal
form of skin cancer. Apart from Programmed Cell Death
Protein 1 (PD-1)/Programmed Death-Ligand 1 (PD-L1)
signaling, there is a lack of knowledge regarding other
immune checkpoint molecules. Recent studies have observed
elevated glycoprotein CD200 (also known as OX-2) mRNA
expression in in different types of tumors, with
CD200R-expressing myeloid cells present in the tumor
microenvironment. However, the potential role of the
CD200/CD200 axis as an additional checkpoint modulator
remains widely unexplored. The aim of this study was to
determine the intratumoral protein expression of CD200 as
well as CD200R in a larger cohort of MCC patients and to
correlate the expression levels with patients' outcomes.In
this multicenter study, we investigated 68 patients with MCC
(68 primary tumors and 15 corresponding metastases).
Immunohistochemistry (IHC) was performed for CD200 as well
as CD200R. Digital quantification and analysis of IHC were
performed using QuPath-0.2.3.CD200 and CD200R expression was
observed in $100\%$ of cases. Univariate analysis revealed
that low CD200 expression in primary tumors (p = 0.0007, HR
9.35), male sex (p = 0.045, HR 2.41), and immunosuppression
(p = 0.0031, HR 6.36) were significantly associated with MCC
relapse. Low CD200 expression was also linked to prior
immune checkpoint inhibitors (ICI) and/or chemotherapy
treatment (p = 0.037). Multivariable analysis confirmed that
low CD200 expression (p = 0.0012, HR 5.25) and
immunosuppression (p = 0.0056, HR 4.11) were independent
predictors of MCC relapse.Expression of CD200/CD200R
proteins is very high in MCC and may thus be of diagnostic
value. More importantly, low intratumoral CD200 protein
expression in primary MCC represents a robust independent
predictor of MCC relapse.},
keywords = {CD200/CC200R-signaling (Other) / Merkel cell carcinoma
(Other) / OX-2 (Other) / immune checkpoints (Other) /
immunotherapy (Other)},
cin = {ED01},
ddc = {610},
cid = {I:(DE-He78)ED01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40075669},
doi = {10.3390/cancers17050822},
url = {https://inrepo02.dkfz.de/record/299784},
}